Skip to main content

Drugs and the Endocrine System

  • Chapter
  • First Online:
Pharmacological Basis of Acute Care

Abstract

The endocrine system regulates many aspects of important physiological processes in the body. Our body produces hormones from different glands and these hormones are kept in balance by various regulatory feedback mechanisms. Autoimmune problems, tumors, metabolic dysregulation and genetic predisposition may disrupt normal regulation of hormones causing excessive production, hormone deficiency or resistance of target organs to hormones. Three hormones, i.e., thyroid hormones, insulin and glucocorticoids are at issue more often compared to the rest of the hormones in the endocrine system. In hyperthyroidism, various antithyroid drugs are used, which target the different stages in thyroid hormone synthesis and release. In hypothyroidism, thyroxine is used in replacement therapy. Diabetes mellitus is an increasing problem worldwide where high blood glucose level is attributed to the deficiency of insulin (Type 1 diabetes) or insulin resistance (Type 2 diabetes.) Type 1 diabetes is managed with human insulin or insulin analogues. In Type 2 diabetes, where there is insulin resistance and relative insulin deficiency, insulin secretagogues and insulin sensitizers are used. Newer agents target the incretin hormones which play an important role in the regulation of insulin, glucose and satiety. The adrenal glands which produce the glucocorticoids and mineralocorticoids regulate many metabolic processes and are important in inflammatory and immune responses. Synthetic glucocorticoids are used clinically in a wide variety of clinical conditions not related to hormone deficiencies due to its potent anti-inflammatory and immunosuppressant effects. However, the use of glucocorticoids therapeutically is associated with many adverse effects, among them impaired response to infection and Cushing’s syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  1. Buchman A. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33(4):289–94.

    Article  CAS  PubMed  Google Scholar 

  2. Hampton J. Thyroid gland disorder emergencies: thyroid storm and myxedema coma. AACN Adv Crit Care. 2013;24(3):325–32.

    Article  PubMed  Google Scholar 

  3. Hermansen K. Insulin and new insulin analogues, insulin pumps and inhaled insulin in type 1 diabetes. In: Mogensen C, editor. Pharmacotherapy of diabetes: new developments improving life and prognosis for diabetic patients. New York: Springer; 2007.

    Google Scholar 

  4. Brent G, Koenig R (2011) Thyroid and anti-thyroid drugs. In: Brunton LL, Blumenthal DK, Murri N, Dandan RH, Knollmann BC (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, 12th edn. McGraw-Hill, New York

    Google Scholar 

  5. Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–79.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Kearney T, Dang C. Diabetic and endocrine emergencies. Postgrad Med J. 2007;83(976):79–86.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Peck TE, Hill SA, Williams M. Pharmacology for anaesthesia and intensive care. 2nd ed. London: Alden Group; 2003. Oxford.

    Google Scholar 

  8. Schäcke H, Döcke W, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96(1):23–43.

    Article  PubMed  Google Scholar 

  9. Stein S, Lamos E, Davis S. A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin Drug Saf. 2013;12(2):153–75.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Torrey S. Recognition and management of adrenal emergencies. Emerg Med Clin North Am. 2005;23(3):687–702.

    Article  PubMed  Google Scholar 

  11. Van Ness-Otunnu R, Hack J. Hyperglycemic crisis. J Emerg Med. 2013;45(5):797–805.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nur Lisa Zaharan M.B.B.Ch, B.A.O., B.Med.Sc., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Zaharan, N.L., Lee, P.K. (2015). Drugs and the Endocrine System. In: Chan, Y., Ng, K., Sim, D. (eds) Pharmacological Basis of Acute Care. Springer, Cham. https://doi.org/10.1007/978-3-319-10386-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-10386-0_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-10385-3

  • Online ISBN: 978-3-319-10386-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics